Company / Current Assets
Sarepta Therapeutics Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.5B
FY2025
5-year range
$2.5B / $3.1B
FY2021-FY2025
Trend
-17.4%
vs FY2024
Sector context
#27 of 213
Health Care
What the data says
Sarepta Therapeutics's current assets of $2.5B is higher than 87% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 10 years, ranging from $373M in FY2016 to $3.1B in FY2024.
Based on SEC 10-K filings.
$2.5B in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Remained stable around $2.5B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 13% of 213This company $2.5B Sector average $2.5B
▼
In line with sector average
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, current assets decreased 17.4% year-over-year.
- Ranks #27 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5B | -17.4% |
| FY2024 | $3.1B | +19.2% |
| FY2023 | $2.6B | +0.8% |
| FY2022 | $2.6B | -1.8% |
| FY2021 | $2.6B | +4.8% |
| FY2020 | $2.5B | +69.2% |
| FY2019 | $1.5B | +3.0% |
| FY2018 | $1.4B | +16.1% |
| FY2017 | $1.2B | +229.0% |
| FY2016 | $373.5M | +66.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026